G

Genprex

D
GNPX
USD
-0.125
(-6.9444%)
Market Closed
14,993.00
Volume
-9.96
EPS
-
Div Yield
-0.105128
P/E
4,335,814.55
Market Cap
Today
-6.9444%
1 Week
-25.721%
1 Month
373.164%
6 Months
-31.911%
12 Months
-85.140%
Year To Date
-81.841%
All Time
0%

Title:
Genprex

Sector:
Healthcare
Industry:
Biotechnology
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for largepatient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
Do you need help or have a question?